Please use this identifier to cite or link to this item: http://repository.uinjkt.ac.id/dspace/handle/123456789/34675
Title: Microsomal Epoxide Hydrolase Polymorphisms, Cigarette Smoking, and Risk of Colorectal Cancer: The Fukuoka Colorectal Cancer Study
Authors: Hoirun Nisa
Sanjeev Budhathoki, Makiko Morita, Kengo Toyomura, Jun Nagano, Keizo Ohnaka, Suminori Kono, Takashi Ueki, Masao Tanaka, Yoshihiro Kakeji, Yoshihiko Maehara, Takeshi Okamura, Koji Ikejiri, Kitaroh Futami, Takafumi Maekawa, Yohichi Yasunami, Kenji Takenaka, Hitoshi Ichimiya,and Reiji Terasaka
Keywords: Microsomal epoxide hydrolase;Cigarette smoking;colorectal cancer;Case-control study
Issue Date: 13-Mar-2012
Publisher: JOURNAL OF MOLECULAR CARCINOGENESIS
Abstract: Microsomal epoxide hydrolase (EPHX1) plays an important role in the activation and detoxification of polycyclic aromatic hydrocarbons, carcinogens found in cigarette smoke. Polymorphisms in exon 3 (Y113H) and exon 4 (H139R) of the EPHX1 have been associated with enzyme activity. We investigated the risk of colorectal cancer in relation to the EPHX1 Y113H and H139R polymorphisms and assessed effect modifications of cigarette smoking and the other covariates. The interaction between the EPHX1 polymorphisms and selected genetic polymorphisms was also examined. We used data from Fukuoka Colorectal Cancer Study, a community-based case–control study, including 685 cases and 778 controls. In-person interviews were conducted to assess lifestyle factors. The EPHX1 Y113H and H139R polymorphisms were determined by the TaqMan assay and the polymerase chain reaction-restriction fragment length polymorphism, respectively. Neither of the two polymorphisms nor the imputed EPHX1 phenotype was associated with colorectal cancer risk. Cigarette smoking and alcohol intake showed no effect modification on the association with the EPHX1 polymorphisms or the imputed EPHX1 phenotype. Increased risks of colorectal cancer associated with the 113Y allele and imputed EPHX1 phenotype were observed among individuals with high body mass index (BMI; 25.0 kg/m2), but not among those with low BMI (<25.0 kg/m2). The risk decreased with an increasing number of the 139R allele in the null genotypes of GSTM1/GSTT1. It is unlikely that the EPHX1 polymorphisms play an importantrole in colorectal carcinogenesis. The observed interactions of the EPHX1 polymorphisms with BMI and the GSTM1/GSTT1 genotypes warrant further investigation.
Description: Article was published in Journal of Molecular Carcinogenesis. An international journal with IF. 4,8
metadata.dc.description.uri: http://onlinelibrary.wiley.com/doi/10.1002/mc.21897/epdf?r3_referer=wol&tracking_action=preview_click&show_checkout=1&purchase_referrer=www.ncbi.nlm.nih.gov&purchase_site_license=LICENSE_DENIED
URI: http://repository.uinjkt.ac.id/dspace/handle/123456789/34675
Appears in Collections:Publisher Version

Files in This Item:
File SizeFormat 
MC_March2012_Hoirun Nisa.pdf88.54 kBAdobe PDFView/Open


Items in UINJKT-IR are protected by copyright, with all rights reserved, unless otherwise indicated.